Baxter International | BAX - 営業利益





営業利益 変化する 日付
Abbott USD 1.85B 399M 2026-03
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 526K 1.96M 2026-03
Avanos Medical USD 8.9M 15.87M 2026-03
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Cooper Companies USD -31M 243.8M 2026-03
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Fresenius EUR 713M 139M 2025-12
Globus Medical USD 164M 17.31M 2026-03
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
ICU Medical USD 26.09M 770K 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
Medtronic USD 2.09B 354M 2026-03
Merit Medical Systems USD 44.16M 10.04M 2026-03
Quest Diagnostics USD 399M 13M 2026-03
Smith & Nephew USD 440M 50M 2025-12
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
Terumo JPY 31.45B 12.43B 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03